Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition

Vallianatou, TheodosiaUppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Medical mass spectrometry imaging (författare)

The neurotransmitter of the cholinergic system, acetylcholine plays a major role in the brain's cognitive function and is involved in neurodegenerative disorders. Here, we present age-related alterations of acetylcholine levels after administration of the acetylcholinesterase inhibitor drug tacrine in normal mice. Using a quantitative, robust and molecular-specific mass spectrometry imaging method we found that tacrine administration significantly raised acetylcholine levels in most areas of sectioned mice brains, inter alia the striatum, hippocampus and cortical areas. However, acetylcholine levels in retrosplenial cortex were significantly lower in 14-month-old than in 12-week-old animals following its administration, indicating that normal aging affects the cholinergic system's responsivity. This small brain region is interconnected with an array of brain networks and is involved in numerous cognitive tasks. Simultaneous visualization of distributions of tacrine and its hydroxylated metabolites in the brain revealed a significant decrease in levels of the metabolites in the 14-month-old mice. The results highlight strengths of the imaging technique to simultaneously investigate multiple molecular species and the drug-target effects in specific regions of the brain. The proposed approach has high potential in studies of neuropathological conditions and responses to neuroactive treatments.

Shariatgorji, MohammadrezaUppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Medical mass spectrometry imaging(Swepub:uu)mohsh560 (författare)
Nilsson, AnnaUppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Medical mass spectrometry imaging(Swepub:uu)annil134 (författare)
Fridjonsdottir, ElvaUppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Medical mass spectrometry imaging(Swepub:uu)elvfr400 (författare)
Källback, PatrikUppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Medical mass spectrometry imaging(Swepub:uu)joaka138 (författare)
Schintu, NicolettaDepartment of Neurology and Clinical Neuroscience, Karolinska Institutet, Stockholm, SE-17176, Sweden (författare)
Svenningsson, PerKarolinska Institutet (författare)
Andrén, Per E.Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab,Medical mass spectrometry imaging(Swepub:uu)perandre (författare)
Uppsala universitetInstitutionen för farmaceutisk biovetenskap (creator_code:org_t)

Ingår i:Neuropsychopharmacology: Springer Science and Business Media LLC44, s. 2091-20980893-133X1740-634X

Av författaren/redakt...: Vallianatou, The ...; Shariatgorji, Mo ...; Nilsson, Anna; Fridjonsdottir, ...; Källback, Patrik; Schintu, Nicolet ...; visa fler...; Svenningsson, Pe ...; Andrén, Per E.; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Medicinska och f ...; och Neurovetenskaper

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.